Real-time SEC alerts Start Free →
Profitelligence
Agilent Technologies Inc.
A HIGH Impact

Agilent Technologies Inc.

Agilent Appoints New Chief Legal Officer

| 8-K |Healthcare

Summary

Agilent Technologies, Inc. announced on May 4, 2026, the appointment of Michael Buckner as its new Chief Legal Officer, effective immediately. This follows the resignation of Bret DiMarco, who will remain as a Special Advisor until December 1, 2026. Buckner brings extensive experience from Danaher Corp., where he led legal strategy for mergers and acquisitions, antitrust, intellectual property transactions, and debt securities.

Profitelligence Profitelligence Alerts

Get alerts for A

Be first to know when Agilent Technologies Inc. files with the SEC.

Set Up Alerts →

Filing Categories

New CEO Appointed CEO Resignation

Advertisement

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

Exchange: NYSE Industry: Diagnostics & Research Company Website →

Official SEC Documents

A
A Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement